Gadodiamide
Paramagnetic Contrast Media
Sold as OMNISCAN
- Drug class
- Paramagnetic Contrast Media
- Availability
- See label
- Routes
- Intravenous
- Markets covered
- 1
- Products on record
- 1
Overview
Gadodiamide is an active pharmaceutical ingredient in the Paramagnetic Contrast Media group (V08CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 1 | November 21, 2025 |
CACanada· Health Canada
1 product
Uses
Omniscan (gadodiamide injection) is indicated for: contrast enhancement of magnetic resonance imaging (MRI), in adults and the pediatric population, of lesions of the central nervous system with expected abnormal vascularity or those thought to cause abnormalities in the blood-brain barrier.
Omniscan has been shown to facilitate visualization of central nervous system lesions including but not limited to tumors. intravenous administration for use in MRI in adults to facilitate the visualization of lesions with abnormal vascularity within the thoracic, abdominal, pelvic cavities, breast, retroperitoneal space and musculoskeletal system.
intravenous administration for use in magnetic resonance angiography (MRA) for the detection and localization of stenosis in renal arteries and aorto-iliac arteries. 1 Pediatrics Pediatrics (2 to 18 years): Based on the data submitted and reviewed by Health Canada, the safety and efficacy of Omniscan in pediatric patients has been established.
Drug interactions
Known interactions involving Gadodiamide. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]Health Canada (DPD) · 02172771 · revised November 21, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.